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1. Introduction 
The number of enzymes and other proteins known 
to be reversibly modified by specific phosphorylation- 
dephosphorylation reactions i steadily increasing [ 1 ]. 
In several cases this phosphate transfer has been 
shown to result from hormone stimulation and to 
influence the activity of key enzymes in mammalian 
metabolism. Phosphorylation might also be involved 
in the regulation of other processes, e.g., protein syn- 
thesis, nervous conduction and secretion [2]. How- 
ever, for the majority of the proteins modified in 
this way present knowledge of the function of the 
phosphorylation seems to be incomplete. 
Hitherto, interest has been focused on intracellu- 
lar and on membrane phosphoproteins. With the 
exception of fibrinogen [3,4] we have found no 
reports on the phosphate content or on any substantial 
phosphorylation f blood plasma proteins. We have 
recently found purified human fibrinogen to be a 
substrate of cyclic AMP-stimulated protein kinase in 
vitro, although the possible physiological effects of 
this phosphorylation are as yet unknown [5]. 
This report describes the phosphorylation f 
human and rat plasma nd serum protein with the 
catalytic subunit of cyclic AMP-stimulated protein 
kinase. 
2. Experimental 
[32p]ATP was a product of New England Nuclear 
(Boston MA). Sephadex was purchased from Pharmacia 
Fine Chemicals (Uppsala). 
The catalytic subunit of cyclic AMP-stimulated 
protein kinase from pig muscle was purified as in [6] 
with some modifications [7]. One unit of protein 
kinase catalyses the incorporation of 1 pmol [32p]. 
phosphate/min into mixed histones (7.5 mg/ml) at 
pH 6.9 and 30°C. 
Blood was collected from healthy human adults or 
from male Sprague-Dawley rats (~300 g body wt) and 
fed ad libitum on ordinary laboratory chow. 
For the preparation of plasma, 4 mM EDTA was 
used as anticoagulant and the blood samples were 
centrifuged immediately. Serum was obtained by cen- 
trifugation of blood samples after 20 rain at room 
temperature. Phenyl methylsulfonyl fluoride (1 mM 
final conc.) was added to freshly prepared plasma nd 
serum in order to minimize proteolytic degradation, 
and serum was made 4 mM with respect o EDTA. 
The material that was not used immediately was 
stored frozen and it was only thawed once. 
Phosphorylation was performed at 30°C with 
0.25 mM [32p]ATP and the indicated amounts of 
protein kinase in the presence of 10 mM magnesium 
acetate. The reaction was interrupted by the addition 
of cold trichloroacetic a id/HaPO4 (10% (w/v)/50 mM 
final conc.). Bovine serum albumin (1 mg/sample) 
was used as coprecipitant. The precipitate was col- 
lected by centrifugation and dissolved in 0.5 ml 
0.2 M NaOH. It was washed 4 times by repeated pre- 
cipitation and dissolution. After the last addition of 
NaOH the radioactivity was measured as Cerenkov 
radiation [8]. Samples phosphorylated for electro- 
phoresis were not precipitated (see below). 
Prior to agarose gel electrophoresis the phospho- 
rylation was interrupted and excess [32p] ATP removed 
by passing the incubation mixture through aSephadex 
G-50 column equilibrated and eluted with 75 mM 
barbituric acid-sodium barbiturate buffer (pH 8.6). 
Electrophoresis in 0.8% (w/v) agarose gel was per- 
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formed essentially as in [9]. The protein was stained 
with Coomassie brilliant blue. When destained, the gel 
plates were covered with falter paper and left over- 
night at room temperature. Then the filter papers 
were removed and the plates were wrapped in thin 
plastic film and subjected to autoradiography. 
Polyacrylamide gel electrophoresis was performed, 
using the slab gel system in [ 10]. Prior to application 
the samples were denatured and reduced in 4 M urea/ 
1% (v/v)/3-mercaptoethanol/1% (w/v) sodium dodecyl 
sulphate (SDS) at 60°C for 60 min. The acrylamide 
concentration of the runner gel was 11% (w/v). After 
staining and drying of the gels, autoradiography was 
carried out. 
[32p] Phosphorylserine was isolated from acid 
hydrolysates of [32P]phosphorylated plasma nd 
serum protein by chromatography on Dowex 50-X8 
and 1 -X8 as in [ 11 ]. 
3. Results 
3.1. G-200 chromatography 
When human and rat plasma or serum was chro- 
matographed on Sephadex G-200, phosphorylatable 
material was eluted as two main peaks (fig. 1). The first 
peak (I) was eluted with the void volume. The second 
(II) was eluted at a position corresponding toM r 
100 000. When the chromatography was performed 
with material that had been incubated with [32p] ATP 
and protein kinase prior to application, again two 
[32p] phosphoprotein peaks were obtained, eluting at 
the same positions as above. 
Fig.2 shows the time course of phosphorylation f 
20 
m 
o 
o 
10 
I A t 
- 20  c E 
o 
c 
o 
z.0 60 80 
Ef f luent  tml )  
% 
20 
10 I II 
4O 60 8O 
Ef f luent  {ml )  
20 
10 o~ 
o 
20 
o~ 
L 
10 
% 
E 
a. 
I II C 
30 50 70 
Ef f luent  (m[) 
E 
30 c 
=o 
c~ 
J 
c 
o 
1.0 
20 
o 
~-10 
I o 
E 
(3_ 
tb 
J, 
3O 
I ]I 
50 70 
Ef f luent  (ml )  
30 
r-a 
"6 
2.0 
o 
10 
Fig.1. Chromatography of 0.5 ml human plasma (A) and 
serum (B) on 1.6 X 61 cm columns and chromatography of 
0.75 ml rat plasma (C) and serum (D) on 1.8 X 40 cm col- 
umns of Sephadex G-200. The columns were equilibrated 
and eluted with 10 mM potassium phosphate buffer/1 mM 
EDTA (pH 7.5): A ~s0 (o - -o ) ;  32p radioactivity incorporated 
into 100 ul samples from separate fractions on incubation for 
20 min (A,B) or 25 min (C,D) with [3~P]ATP (57 000 cpm/ 
nmol) in the absence (A - -A)  or presence (e - -e )  of pro- 
tein kinase (1000 units/test in A,B; 600 units/test in C.D). 
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Fig.2. [32P]Phosphate incorporation into peak I and peak II 
material from human plasma nd serum. Each point repre- 
sents the mean of two determinations. The incubation mix- 
tures contained 200 ~tl pooled material from the G-200 
chromatography and 2000 units protein kinase. Plasma peak 
I (m- -o ) ,  plasma peak II (A- -A) ,  serum peak I (o - -o ) ,  
serum peak II (zx__:~). 
3'0 
tively. Thus, in this case no significant difference 
between plasma and serum was detected regarding the 
amount  of [32p] phosphate incorporated into fraction 
I. This is consistent with the results depicted in 
fig.lC,D. 
3.2. Agarose gel electrophoresis 
• When human plasma was subjected to agarose gel 
electrophoresis after incubation with [32p] ATP and 
protein kinase the radioactivity appeared in two 
main regions, coinciding with the c~2- and the fibrin- 
ogen-band, respectively. In serum treated in the same 
way, the radioactivity was found corresponding to
the c~2-band (fig.3). Plasma peak I was found to be 
material from peak I and peak II from human plasma 
and serum. No plateau value was obtained for frac- 
t ion I from plasma. The phosphate incorporation i to 
fraction I from serum was markedly lower and fol- 
lowed another time course. The [3Zp] phosphate 
incorporat ion into material from peak I and peak II 
from rat plasma and serum under similar condit ions 
amounted to higher values, corresponding to ~20 nmol 
and 10 nmol [32p]phosphate/ml plasma or serum in 
a 30 min incubat ion period for peak I and II, respec- 
Fig.3. Agarose gel electrophoresis of human serum (S) and 
plasma (P) after incubation with [32 p] ATP and protein 
kinase. Autoradiogram (left) and protein pattern (right). 
The positions of the application slit (A) and of the albumin 
(1), % (2), c~: (3), t31 (4), t32 (5) and fibrinogen (6) bands are 
indicated in the figure. 
Fig.4. SDS-Polyacrylamide gelelectrophoresis under educing 
conditions of samples from a Sephadex G-200 chromatog- 
raphy of human plasma, incubated with [ 32 p] ATP and pro- 
tein kinase prior to application on the column. Protein pat- 
tern (above) and autoradiogram (below). The Mr-values of 
the reference proteins (R) are indicated in the figure. The 
figures 35-60 indicate fraction umbers, where 35 represents 
a fraction in the middle of peak I and 56 represents a fraction 
in the middle of peak II (see fig.lA). 
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4. Discussion 
Fig.5. SDS-Polyacrylamide g l electrophoresis under reducing 
conditions of samples from rat peak I and peak II (fig.l). Rat 
plasma peak 1 (RPI), rat plasma peak II (RPII), rat serum 
peak I (RSI) and rat serum peak II (RSII). Autoradiogram. 
the source of the radioactivity coinciding with the 
fribrinogen band and peak II was the source of the 
radioactive material migrating with the c~2-fraction. 
On separation of rat plasma proteins by agarose gel 
electrophoresis after phosphorylation, the radioactiv- 
ity appeared in a dominating fraction coinciding with 
the albumin band and in a minor band just anodal to 
the application slit. The latter component was not 
found in serum. 
3.3. SDS-polyacrylamide g l electrophoresis 
The [32p] phosphoprotein of peak II from human 
plasma or serum was resolved into two components 
by SDS-polyacrylamide gel el ctrophoresis under 
reducing conditions (rigA). The Mr-values were 
estimated to be 80 000 and 67 000, respectively. 
Only one ph0sphorylated component, with est. 
M r 67 000, was detected by this method in plasma 
peak I. Due to the low degree of phosphorylation 
peak I from serum was not investigated in this respect. 
The [32p]phosphoprotein of peak II from rat 
plasma or serum appeared on the polyacrylamide g ls 
as a component with M r ~ 80 000 (fig.5). In addition 
there was a component with M r > 100 000. The 
32p-radioactivity of peak I appeared in the high M r 
region, except for 2 minor bands derived from plasma 
and corresponding toM r ~ 60 000 and 65 000. 
3.4. Isolation of[ 32P]phosphorylserine 
From acid hydrolysates of [32p] phosphorylated 
peak I and peak II material from human or rat plasma, 
[a2p] phosphorylserine but no [a2p] phosphoryl- 
threonine could be isolated. 
The data obtained indicated that fibrinogen was 
the main phosphorylatable component of fraction I
from human blood under the conditions used, since 
the [32p]phosphoprotein was eluted from Sephadex 
G-200 at the same position as is fibrinogen, it comi- 
grated with the fibrinogen band on agarose gel elec- 
trophoresis and the M r as estimated by polyacryl- 
amide gel electrophoresis in detergent under reducing 
conditions was 67 000, similar to theM r of the a-chain 
of human fib rinogen. When purified human fibrinogen 
is phosphorylated with cyclic AMP-stimulated protein 
kinase, the phosphate is incorporated primarily into 
the s-chain [5]. Furthermore, the phosphorylation f 
purified human fibrinogen follows a time course 
similar to that obtained for fraction I from human 
plasma. In addition, the phosphate incorporation i to 
fraction I from serum was much lower. 
Rat fibrinogen, however, did not seem to be a major 
phosphorylatable component in our experiments. The 
phosphate incorporation into fraction I was not signifi- 
cantly lower in serum than in plasma nd only a minor 
fraction of the phosphoprotein seemed to migrate 
with fibrinogen on agarose gel electrophoresis. 
The identity of the phosphorylatable components 
of fraction I from rat blood and of fraction II from 
rat or human blood is not yet clear. Caution in the 
interpretation of electrophoretic mobility in the 
agarose gels is needed, since the degree of phosphoryl- 
ation might influence the migration of the protein. 
For proteins phosphorylated stoichiometrically at 
a significant rate it is reasonable to assume that the 
phosphorylation might be of physiological importance. 
The phosphorylation f plasma nd serum proteins 
was relatively rapid. Only a limited number of pro- 
teins were phosphorylated (fig.3-5) and the amount 
of phosphate incorporated was fairly large. This is 
suggestive of a possible physiological role of the 
phosphorylation. I teresting in this context might 
be the stimulatory effects of stress and different 
hormones on blood coagulation and fibrinolysis [12]. 
The blank values obtained on incubation of plasma 
and serum with ATP and Mg 2+ in the absence of 
added protein kinase were low and did not increase 
in the presence of cyclic AMP (10/aM). This indicated 
that the source of the protein kinase that might be 
operative in vivo in the phosphorylation f plasma 
proteins hould be somewhere else, e.g., in the liver 
or in the formed elements of blood. 
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